These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 9190855)

  • 1. The passage of azidodeoxythymidine into and within the central nervous system: does it follow the parent compound, thymidine?
    Thomas SA; Segal MB
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1211-8. PubMed ID: 9190855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo evidence for carrier-mediated efflux transport of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine across the blood-brain barrier via a probenecid-sensitive transport system.
    Takasawa K; Terasaki T; Suzuki H; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Apr; 281(1):369-75. PubMed ID: 9103519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain iron homeostasis.
    Moos T
    Dan Med Bull; 2002 Nov; 49(4):279-301. PubMed ID: 12553165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transport of the anti-HIV drug, 2',3'-didehydro-3'-deoxythymidine (D4T), across the blood-brain and blood-cerebrospinal fluid barriers.
    Thomas SA; Segal MB
    Br J Pharmacol; 1998 Sep; 125(1):49-54. PubMed ID: 9776343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low blood-brain barrier permeability to azidothymidine (AZT), 3TC, and thymidine in the rat.
    Wu D; Clement JG; Pardridge WM
    Brain Res; 1998 Apr; 791(1-2):313-6. PubMed ID: 9593963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distributed model analysis of 3'-azido-3'-deoxythymidine and 2',3'-dideoxyinosine distribution in brain tissue and cerebrospinal fluid.
    Takasawa K; Terasaki T; Suzuki H; Ooie T; Sugiyama Y
    J Pharmacol Exp Ther; 1997 Sep; 282(3):1509-17. PubMed ID: 9316866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The entry of [D-penicillamine2,5]enkephalin into the central nervous system: saturation kinetics and specificity.
    Thomas SA; Abbruscato TJ; Hruby VJ; Davis TP
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1235-40. PubMed ID: 9067309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors.
    Masereeuw R; Jaehde U; Langemeijer MW; de Boer AG; Breimer DD
    Pharm Res; 1994 Feb; 11(2):324-30. PubMed ID: 8165196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The distribution of the HIV protease inhibitor, ritonavir, to the brain, cerebrospinal fluid, and choroid plexuses of the guinea pig.
    Anthonypillai C; Sanderson RN; Gibbs JE; Thomas SA
    J Pharmacol Exp Ther; 2004 Mar; 308(3):912-20. PubMed ID: 14634041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential transport of a secretin analog across the blood-brain and blood-cerebrospinal fluid barriers of the mouse.
    Banks WA; Goulet M; Rusche JR; Niehoff ML; Boismenu R
    J Pharmacol Exp Ther; 2002 Sep; 302(3):1062-9. PubMed ID: 12183664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Saturation kinetics, specificity and NBMPR sensitivity of thymidine entry into the central nervous system.
    Thomas SA; Segal MB
    Brain Res; 1997 Jun; 760(1-2):59-67. PubMed ID: 9237518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of transport inhibitors and additional anti-HIV drugs on the movement of lamivudine (3TC) across the guinea pig brain barriers.
    Gibbs JE; Rashid T; Thomas SA
    J Pharmacol Exp Ther; 2003 Sep; 306(3):1035-41. PubMed ID: 12766261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microdialysis study of zidovudine (AZT) transport in rat brain.
    Dykstra KH; Arya A; Arriola DM; Bungay PM; Morrison PF; Dedrick RL
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1227-36. PubMed ID: 8263784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and metabolism of cytosine arabinoside in the central nervous system.
    Spector R
    J Pharmacol Exp Ther; 1982 Jul; 222(1):1-6. PubMed ID: 7086691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zidovudine and ursodeoxycholic acid conjugation: design of a new prodrug potentially able to bypass the active efflux transport systems of the central nervous system.
    Dalpiaz A; Paganetto G; Pavan B; Fogagnolo M; Medici A; Beggiato S; Perrone D
    Mol Pharm; 2012 Apr; 9(4):957-68. PubMed ID: 22356133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of zidovudine uptake by dehydroepiandrosterone sulfate in rat syncytiotrophoblast cell line TR-TBT 18d-1.
    Nishimura T; Seki Y; Sato K; Chishu T; Kose N; Terasaki T; Kang YS; Sai Y; Nakashima E
    Drug Metab Dispos; 2008 Oct; 36(10):2080-5. PubMed ID: 18653745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of efflux into the blood and brain of intraventricularly perfused [3H]thymidine in the anaesthetized rabbit.
    Thomas SA; Davson H; Segal MB
    Exp Physiol; 1997 Jan; 82(1):139-48. PubMed ID: 9023512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons.
    Kleine TO; Benes L
    Cytometry A; 2006 Mar; 69(3):147-51. PubMed ID: 16479603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidine transport in the central nervous system.
    Spector R
    J Neurochem; 1980 Nov; 35(5):1092-8. PubMed ID: 7452306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of the choroid plexus in central nervous system inflammation.
    Engelhardt B; Wolburg-Buchholz K; Wolburg H
    Microsc Res Tech; 2001 Jan; 52(1):112-29. PubMed ID: 11135454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.